Quoin Pharmaceuticals(QNRX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

QNRX Quoin Pharmaceuticals

Pre-Mkt 10-27 05:32:39 EDT

4.01

-0.01

-0.25%

High4.21	Low3.91	Vol14.89K
Open3.96	D1 Closing4.02	Amplitude7.46%
Mkt Cap19.26M	Tradable Cap18.56M	Total Shares4.80M
T/O60.07K	T/O Rate0.32%	Tradable Shares4.63M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"QNRX","market":"US","secType":"STK","nameCN":"Quoin Pharmaceuticals","latestPrice":4.01,"timestamp":1793044800000,"preClose":4.02,"halted":0,"volume":14890,"delay":0,"changeRate":-0.0024875621890546734,"floatShares":4628002,"shares":4804200,"eps":-8.521029,"marketStatus":"Pre-Mkt","change":-0.01,"latestTime":"10-27 05:32:39 EDT","open":3.96,"high":4.21,"low":3.91,"amount":60073.79434000001,"amplitude":0.074627,"askPrice":4.62,"askSize":100,"bidPrice":3.36,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-8.521029,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1793107800000},"marketStatusCode":1,"adr":0,"adrRate":35,"exchange":"NASDAQ","adjPreClose":4.01,"postHourTrading":{"tag":"盘后","latestPrice":4.01,"preClose":4.01,"latestTime":"19:30 EDT","volume":25,"amount":97.6814,"timestamp":1793057403651,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.644250093862497},"requestUrl":"/m/hq/s/QNRX","defaultTab":"news","newsList":[{"id":"2676662616","title":"Quoin Reports Qrx003 Clears Skin in Pediatric Netherton Syndrome Case Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2676662616","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2676662616?lang=en_us&edition=fundamental","pubTime":"2026-10-20 18:31","pubTimestamp":1792492309,"startTime":"0","endTime":"0","summary":"Quoin reports QRX003 clears skin in pediatric Netherton syndrome case studyQuoin Pharmaceuticals announced publication of a peer-reviewed QRX003 pediatric Netherton syndrome case report in Dermatology","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261020:nNDL8kw3bP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QNRX","IE00BKPKM429.USD","IE00BQXX3D17.EUR","BK4139","SG9999014021.USD","BCDF","IE00BQXX3C00.GBP","IE00BN0W2T93.GBP","SG9999014013.SGD","BK4112","LU2210150020.SGD","LU2210149790.SGD","SG9999014005.SGD","IE00B64PRP62.GBP","IE00BQXX3F31.USD","BK4585","IE00BN0W2W23.USD","BK4588","SG9999014039.USD","NDAQ","IE00BGHQF748.EUR","LU2095319765.USD","LU0314104364.USD","IE00B3QW5Z07.USD","IE00BN0W2V16.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676662408","title":"Quoin Pharmaceuticals Announces Publication of Peer-Reviewed Paper on QRX003 for Netherton Syndrome in Dermatology and Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2676662408","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2676662408?lang=en_us&edition=fundamental","pubTime":"2026-10-20 18:30","pubTimestamp":1792492200,"startTime":"0","endTime":"0","summary":"– Peer-Reviewed Paper Introducing QRX003 and Its Mechanism of Action in Netherton Syndrome Now Published – Case Report Details 21 Months of Compassionate Use Treatment in a Pediatric Patient – Patient","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/20/3384191/0/en/quoin-pharmaceuticals-announces-publication-of-peer-reviewed-paper-on-qrx003-for-netherton-syndrome-in-dermatology-and-therapy.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","QNRX","IGA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676461685","title":"Quoin Pharmaceuticals Initiated at Buy by Canaccord Genuity","url":"https://stock-news.laohu8.com/highlight/detail?id=2676461685","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2676461685?lang=en_us&edition=fundamental","pubTime":"2026-10-19 20:23","pubTimestamp":1792412580,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/QNRX/analyst-ratings","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","QNRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676504919","title":"Canaccord Genuity Initiates Quoin Pharmaceuticals at Buy With $18 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2676504919","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2676504919?lang=en_us&edition=fundamental","pubTime":"2026-10-19 17:35","pubTimestamp":1792402531,"startTime":"0","endTime":"0","summary":"Quoin Pharmaceuticals (QNRX) has an average rating of buy and mean price target of $21.57, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from maj","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["QNRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675434306","title":"Quoin’s QRX003 granted Orphan Drug Designation in Europe","url":"https://stock-news.laohu8.com/highlight/detail?id=2675434306","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675434306?lang=en_us&edition=fundamental","pubTime":"2026-10-14 18:35","pubTimestamp":1791974152,"startTime":"0","endTime":"0","summary":"Quoin Pharmaceuticals (QNRX) announces that its lead product candidate QRX003 has been granted Orphan Drug Designation in Europe by the European Me...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/quoins-qrx003-granted-orphan-drug-designation-in-europe-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/quoins-qrx003-granted-orphan-drug-designation-in-europe-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","QNRX","EPV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675431573","title":"Quoin Says EMA Grants Orphan Drug Designation for Qrx003 in Peeling Skin Syndrome","url":"https://stock-news.laohu8.com/highlight/detail?id=2675431573","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675431573?lang=en_us&edition=fundamental","pubTime":"2026-10-14 18:30","pubTimestamp":1791973846,"startTime":"0","endTime":"0","summary":"Quoin says EMA grants orphan drug designation for QRX003 in peeling skin syndromeQuoin Pharmaceuticals received EMA orphan drug designation for QRX003 to treat Peeling Skin Syndrome.Status supports pr","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261014:nNDLc11bky:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014039.USD","IE00BQXX3F31.USD","SG9999014005.SGD","QNRX","SG9999014021.USD","NDAQ","IE00B64PRP62.GBP","BK4588","IE00BN0W2V16.EUR","LU2210149790.SGD","IE00B3QW5Z07.USD","IE00BQXX3C00.GBP","BK4585","IE00BN0W2W23.USD","IE00BN0W2T93.GBP","BK4139","LU2210150020.SGD","IE00BGHQF748.EUR","LU0314104364.USD","IE00BKPKM429.USD","IE00BQXX3D17.EUR","BCDF","LU2095319765.USD","BK4112","SG9999014013.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674729948","title":"BTIG Initiates Quoin Pharmaceuticals at Buy With $14 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2674729948","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674729948?lang=en_us&edition=fundamental","pubTime":"2026-10-12 19:38","pubTimestamp":1791805112,"startTime":"0","endTime":"0","summary":"Quoin Pharmaceuticals. Ltd (QNRX) has an average rating of buy and mean price target of $22.17, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research fro","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["QNRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674874650","title":"Quoin Pharmaceuticals Ltd : Btig Initiates Coverage with Buy Rating; Target Price $14","url":"https://stock-news.laohu8.com/highlight/detail?id=2674874650","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674874650?lang=en_us&edition=fundamental","pubTime":"2026-10-12 19:07","pubTimestamp":1791803260,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261012:nFWN45Y24C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["QNRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674797738","title":"Quoin Pharmaceuticals Price Target Announced at $14.00/Share by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2674797738","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674797738?lang=en_us&edition=fundamental","pubTime":"2026-10-12 18:29","pubTimestamp":1791800940,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/QNRX/analyst-ratings","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QNRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673305878","title":"Quoin Says Qrx003 Pediatric Compassionate-Use Case Report Accepted for Publication in Dermatology and Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2673305878","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673305878?lang=en_us&edition=fundamental","pubTime":"2026-10-06 18:30","pubTimestamp":1791282634,"startTime":"0","endTime":"0","summary":"Quoin says QRX003 pediatric compassionate-use case report accepted for publication in Dermatology and TherapyQuoin Pharmaceuticals announced acceptance of a peer-reviewed paper on QRX003 for Netherton","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261006:nNDL6MHqkc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IE00BKPKM429.USD","LU2210150020.SGD","SG9999014039.USD","IE00BGHQF748.EUR","LU0314104364.USD","BCDF","BK4588","IE00BN0W2T93.GBP","IE00B64PRP62.GBP","LU2095319765.USD","SG9999014021.USD","QNRX","SG9999014005.SGD","SG9999014013.SGD","IE00BQXX3D17.EUR","IE00BQXX3C00.GBP","BK4585","NDAQ","IE00BQXX3F31.USD","BK4112","IE00B3QW5Z07.USD","IE00BN0W2W23.USD","LU2210149790.SGD","IE00BN0W2V16.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669484141","title":"Quoin Pharmaceuticals Price Target Announced at $20.00/Share by Lake Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2669484141","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669484141?lang=en_us&edition=fundamental","pubTime":"2026-09-23 22:32","pubTimestamp":1790173920,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/QNRX/analyst-ratings","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QNRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669144430","title":"Quoin Pharma Wins FDA Fast Track Status for Qrx003 in Peeling Skin Syndrome","url":"https://stock-news.laohu8.com/highlight/detail?id=2669144430","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669144430?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:33","pubTimestamp":1790080412,"startTime":"0","endTime":"0","summary":"Quoin Pharma wins FDA fast track status for QRX003 in peeling skin syndromeFDA granted Fast Track designation to Quoin’s QRX003 for Peeling Skin Syndrome, a rare genetic skin disease with no approved ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nNDL2zjv71:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2095319765.USD","IE00BQXX3C00.GBP","BK4588","SG9999014021.USD","IE00BKPKM429.USD","BK4139","IE00BN0W2V16.EUR","QNRX","IE00BN0W2T93.GBP","IE00BQXX3D17.EUR","LU2210149790.SGD","SG9999014005.SGD","SG9999014013.SGD","IE00B64PRP62.GBP","IE00BGHQF748.EUR","SG9999014039.USD","IE00BN0W2W23.USD","BK4112","BK4585","LU2210150020.SGD","IE00B3QW5Z07.USD","NDAQ","LU0314104364.USD","BCDF","IE00BQXX3F31.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668797598","title":"Quoin Pharmaceuticals registers to sell 9.37M ADRs for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2668797598","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668797598?lang=en_us&edition=fundamental","pubTime":"2026-09-19 05:05","pubTimestamp":1789765509,"startTime":"0","endTime":"0","summary":"This filing relates to the offer and sale from time to time by the selling stockholders of up to 9.37M American depositary shares. The company is n...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/quoin-pharmaceuticals-registers-to-sell-9-37m-adrs-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/quoin-pharmaceuticals-registers-to-sell-9-37m-adrs-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","SCHY","QNRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666852516","title":"Quoin Pharmaceuticals Gains FDA Rare Pediatric Designation","url":"https://stock-news.laohu8.com/highlight/detail?id=2666852516","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666852516?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:33","pubTimestamp":1789072437,"startTime":"0","endTime":"0","summary":"Quoin Pharmaceuticals ( ($QNRX) ) has issued an update. On September 8, 2026, Quoin Pharmaceuticals reported that the U.S. Food and Drug Administra...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/quoin-pharmaceuticals-gains-fda-rare-pediatric-designation?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/quoin-pharmaceuticals-gains-fda-rare-pediatric-designation?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LABU","BK4588","QNRX","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666959327","title":"Quoin Evaluates Qrx003 in Phase 2/3 Trial for Netherton Syndrome","url":"https://stock-news.laohu8.com/highlight/detail?id=2666959327","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666959327?lang=en_us&edition=fundamental","pubTime":"2026-09-10 20:30","pubTimestamp":1789043428,"startTime":"0","endTime":"0","summary":"Quoin evaluates QRX003 in Phase 2/3 trial for Netherton syndromeQuoin Pharmaceuticals highlighted positive interim results already released on Aug. 28 from its ongoing Phase 2/3 QRX003 trial in Nether","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDL9n9lk9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","SG9999014013.SGD","IE00BGHQF748.EUR","BK4139","QNRX","BK4112","IE00BQXX3D17.EUR","LU2210150020.SGD","LU2210149790.SGD","BK4585","IE00B64PRP62.GBP","BCDF","IE00BN0W2W23.USD","IE00BQXX3C00.GBP","BK4588","LU0314104364.USD","IE00BKPKM429.USD","IE00B3QW5Z07.USD","SG9999014005.SGD","SG9999014039.USD","LU2095319765.USD","IE00BN0W2V16.EUR","SG9999014021.USD","IE00BQXX3F31.USD","IE00BN0W2T93.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666595833","title":"Quoin Pharmaceuticals Releases New NETHERTON NOW Video: Aminah’s Story Featuring Laura Wright-Sexton, MD, the Physician Who First Met Her Daughter in the ICU","url":"https://stock-news.laohu8.com/highlight/detail?id=2666595833","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666595833?lang=en_us&edition=fundamental","pubTime":"2026-09-10 20:30","pubTimestamp":1789043400,"startTime":"0","endTime":"0","summary":"This New Video Explores the Daily Realities of Raising a Child with Netherton Syndrome, and Its Impact on the Whole FamilyASHBURN, Va., Sept.  10, 2026 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/10/3359506/0/en/quoin-pharmaceuticals-releases-new-netherton-now-video-aminah-s-story-featuring-laura-wright-sexton-md-the-physician-who-first-met-her-daughter-in-the-icu.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QNRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665537583","title":"Quoin Pharmaceuticals granted Rare Pediatric Disease Designation for QRX003","url":"https://stock-news.laohu8.com/highlight/detail?id=2665537583","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665537583?lang=en_us&edition=fundamental","pubTime":"2026-09-08 21:05","pubTimestamp":1788872727,"startTime":"0","endTime":"0","summary":"Quoin Pharmaceuticals (QNRX) announced that the FDA has granted Rare Pediatric Disease Designation for the company’s lead asset, QRX003, for the tr...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/quoin-pharmaceuticals-granted-rare-pediatric-disease-designation-for-qrx003-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/quoin-pharmaceuticals-granted-rare-pediatric-disease-designation-for-qrx003-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4585","QNRX","BK4139","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665789303","title":"Quoin Says FDA Grants Rare Pediatric Disease Designation for Qrx003 in Peeling Skin Syndrome","url":"https://stock-news.laohu8.com/highlight/detail?id=2665789303","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665789303?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:34","pubTimestamp":1788870852,"startTime":"0","endTime":"0","summary":"Quoin says FDA grants rare pediatric disease designation for QRX003 in peeling skin syndromeFDA granted Rare Pediatric Disease designation for QRX003 in Peeling Skin Syndrome, extending a prior design","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL3wnZkK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2V16.EUR","IE00BQXX3F31.USD","NDAQ","SG9999014013.SGD","SG9999014039.USD","IE00B64PRP62.GBP","LU2210149790.SGD","IE00BKPKM429.USD","IE00BN0W2W23.USD","LU2210150020.SGD","SG9999014021.USD","IE00BGHQF748.EUR","BK4585","IE00BN0W2T93.GBP","IE00B3QW5Z07.USD","LU2095319765.USD","BK4112","BCDF","IE00BQXX3D17.EUR","IE00BQXX3C00.GBP","SG9999014005.SGD","BK4139","QNRX","BK4588","LU0314104364.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664806777","title":"Analysts’ Top Healthcare Picks: Dogwood Therapeutics (DWTX), Quoin Pharmaceuticals (QNRX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664806777","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664806777?lang=en_us&edition=fundamental","pubTime":"2026-09-04 02:30","pubTimestamp":1788460208,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Dogwood Therapeutics (DWTX) and Quoin Pharmaceutical...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-dogwood-therapeutics-dwtx-quoin-pharmaceuticals-qnrx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-dogwood-therapeutics-dwtx-quoin-pharmaceuticals-qnrx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","LU0029874061.USD","LABU","XBI","QNRX","BK4139","BK4585","DWTX","HCSG","LU0128526141.USD","BK4588","XLV","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664952860","title":"Quoin Pharmaceuticals Director Anthony James Culverwell Acquires Shares Worth $29,988.48","url":"https://stock-news.laohu8.com/highlight/detail?id=2664952860","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664952860?lang=en_us&edition=fundamental","pubTime":"2026-09-02 09:38","pubTimestamp":1788313136,"startTime":"0","endTime":"0","summary":"Quoin Pharmaceuticals director Anthony James Culverwell acquires shares worth $29,988.48Quoin Pharmaceuticals director Anthony James Culverwell bought 6,146 ADSs at USD 4.88 in a private placement.Hol","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDLbmH65M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Quoin Pharmaceuticals Director Anthony James Culverwell Acquires Shares Worth $29,988.48","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QNRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.quoinpharma.com","stockEarnings":[{"period":"1week","weight":0.0075},{"period":"1month","weight":-0.3764},{"period":"3month","weight":-0.0452},{"period":"6month","weight":-0.3238},{"period":"1year","weight":-0.6903},{"period":"ytd","weight":-0.7221}],"compareEarnings":[{"period":"1week","weight":-0.0014},{"period":"1month","weight":-0.0078},{"period":"3month","weight":0.0331},{"period":"6month","weight":0.0756},{"period":"1year","weight":0.1301},{"period":"ytd","weight":0.1224}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Quoin Pharmaceuticals, Ltd., a clinical stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases. Its lead product is QRX003, a topical lotion to treat Netherton Syndrome (NS). The company is also developing QRX004 for the treatment of recessive dystrophic epidermolysis bullosa; QRX007 to treat NS; and QRX008 for the treatment of scleroderma. It has a research agreement with Queensland University of Technology; a license agreement with Skinvisible Inc.; consulting agreements with Axella Research LLC; and a Master Service Agreement with Therapeutics Inc. The company was founded in 2018 and is based in Ashburn, Virginia. Quoin Pharmaceuticals, Ltd. operates as a subsidiary of Skinvisible, Inc.","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.264124},{"month":2,"riseRate":0.2,"avgChangeRate":-0.199382},{"month":3,"riseRate":0.2,"avgChangeRate":-0.222445},{"month":4,"riseRate":0.2,"avgChangeRate":-0.15112},{"month":5,"riseRate":0.4,"avgChangeRate":-0.043514},{"month":6,"riseRate":0.4,"avgChangeRate":-0.066019},{"month":7,"riseRate":0.4,"avgChangeRate":-0.043305},{"month":8,"riseRate":0.6,"avgChangeRate":0.001072},{"month":9,"riseRate":0,"avgChangeRate":-0.220179},{"month":10,"riseRate":0.4,"avgChangeRate":0.15535},{"month":11,"riseRate":0.4,"avgChangeRate":0.035616},{"month":12,"riseRate":0.2,"avgChangeRate":-0.187047}],"exchange":"NASDAQ","name":"Quoin Pharmaceuticals","nameEN":"Quoin Pharmaceuticals","securityTypeName":"DR","adrRate":"1:35"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Quoin Pharmaceuticals(QNRX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Quoin Pharmaceuticals(QNRX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Quoin Pharmaceuticals,QNRX,Quoin Pharmaceuticals股票,Quoin Pharmaceuticals股票老虎,Quoin Pharmaceuticals股票老虎国际,Quoin Pharmaceuticals行情,Quoin Pharmaceuticals股票行情,Quoin Pharmaceuticals股价,Quoin Pharmaceuticals股市,Quoin Pharmaceuticals股票价格,Quoin Pharmaceuticals股票交易,Quoin Pharmaceuticals股票购买,Quoin Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Quoin Pharmaceuticals(QNRX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Quoin Pharmaceuticals(QNRX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}